Registration Dossier

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)
Additional information:

One assay on skin sensitisation of butyl methoxydibenzoylmethane (BMDBM) was provided:

A GPMT was performed on guinea pigs .

BMDBM did not show any sensitising potential. It can therefore be concluded beyond any reasonable doubt that topical application of BMDBM is not likely to cause skin sensitization.


Migrated from Short description of key information:
Butyl methoxydibenzoylmethane (BMDBM) showed no skin sensitising potential in a GMPT study on guinea pigs.

Justification for selection of skin sensitisation endpoint:
Comparable to guideline study with deficiencies in reporting.

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

As no skin sensitising potential of BMDBM was observed, no classification as skin sensitizer is required.